Ionis Pharmaceuticals IONS
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$34.51M (6 inflow days, 14 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 45.3% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 12.58% to 12.74% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +2,488,174 | 7.9% |
| Morgan Stanley | Public Company | 2026/Q3 | +1,862,501 | 1.9% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +1,862,501 | 1.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,376,052 | 3.4% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +1,013,883 | 0.7% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +883,460 | 1.8% |
| ARK Investment Management LLC | Mutual Fund | 2026/Q3 | +622,392 | 0.6% |
| GW&K Investment Management, LLC | Mutual Fund | 2026/Q3 | +594,349 | 0.8% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +566,624 | 0.4% |
| Global Alpha Capital Management Ltd. | Mutual Fund | 2026/Q3 | +436,785 | 0.3% |
| Barclays Bank Plc | Private Company | 2026/Q3 | +431,283 | 0.3% |
| Deutsche Asset & Wealth Management | Mutual Fund | 2026/Q3 | +362,114 | 0.3% |
| Royal Bank of Canada | Public Company | 2026/Q3 | +2,567,204 | 1.7% |
| Capital Research | Mutual Fund | 2026/Q3 | +1,315,542 | 13.7% |
| Barclays PLC | Public Company | 2026/Q3 | +1,294,472 | 0.9% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 9 Nov 2026 | Michael Hayden | Independent Director | Open Market Acquisition | +5,000 | $29.64 | 81,298 |
| 15 Oct 2026 | Shannon L. Devers | Executive VP & Chief Human Resource Officer | Intent to Sell (Form 144) | -1,357 | $44.00 | – |
| 15 Oct 2026 | Eric Swayze | Executive Vice President & Head of Research | Derivative Exercise and Sale | -53 | $43.54 | 22,149 |
| 15 Oct 2026 | Shannon L. Devers | Executive VP & Chief Human Resource Officer | Derivative Exercise and Sale | -1,357 | $43.54 | 17,811 |
| 14 Oct 2026 | Eric Swayze | Executive Vice President & Head of Research | Derivative Exercise and Retained | +72 | – | 22,149 |
| 14 Oct 2026 | Shannon L. Devers | Executive VP & Chief Human Resource Officer | Derivative Exercise and Retained | +1,463 | – | 17,811 |
| 30 Aug 2026 | C. Bennett | Chief Scientific Officer | Other Acquisition | +110 | $51.31 | 75,128 |
| 30 Aug 2026 | Brett Monia | Chief Executive Officer | Other Acquisition | +98 | $51.31 | 242,760 |
| 30 Aug 2026 | Patrick O'Neil | Executive VP, Chief Legal Officer, General Counsel & Corporate Secretary | Other Acquisition | +63 | $51.31 | 59,205 |
| 30 Aug 2026 | Brian Birchler | Executive Vice President of Corporate & Development Operations | Other Acquisition | +58 | $51.31 | 102,883 |
| 30 Jul 2026 | Michael Hayden | Independent Director | Open Market Acquisition | +20,000 | $53.38 | 78,298 |
| 14 Jul 2026 | Joan Herman | Independent Director | Derivative Exercise and Retained | +5,220 | – | 51,306 |
| 14 Jul 2026 | Spencer Berthelsen | Independent Director | Derivative Exercise and Retained | +5,220 | – | 161,303 |
| 14 Jul 2026 | Ludwig Hantson | Director | Other Derivative Acquisition | +3,399 | – | 3,399 |
| 14 Jul 2026 | Peter Reikes | Director | Other Derivative Acquisition | +3,399 | – | 3,399 |
| 6 Jul 2026 | C. Bennett | Chief Scientific Officer | Other Acquisition | +15,000 | – | 75,018 |
| 6 Jul 2026 | C. Bennett | Chief Scientific Officer | Automatic Disposition | -20,536 | $85.46 | 75,018 |
| 6 Jul 2026 | C. Bennett | Chief Scientific Officer | Other Derivative Disposition | -15,000 | – | 12,109 |
| 6 Jul 2026 | Allene Diaz | Independent Director | Derivative Exercise and Sale | -10,111 | $85.42 | 3,811 |
| 6 Jul 2026 | Holly Kordasiewicz | Chief Development Officer | Automatic Disposition | -362 | $84.30 | 22,096 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 21,165,846 | 12.7% | 8.4 |
| 15 Oct 2026 | 20,653,026 | 12.4% | 7.7 |
| 30 Sep 2026 | 22,508,744 | 13.5% | 4.6 |
| 15 Sep 2026 | 20,890,252 | 12.6% | 5.2 |
| 31 Aug 2026 | 20,924,638 | 12.6% | 9.2 |
| 14 Aug 2026 | 20,909,181 | 12.6% | 9.6 |
No comments yet — be the first to weigh in on IONS.
Sign in to join the discussion.